Acrivon Therapeutics (ACRV) Return on Assets [ROA] (2022 - 2026)
Acrivon Therapeutics (ACRV) posted Return on Assets [ROA] of -75.75% for Q2 2026, down 19.38 percentage points from -56.37% a year earlier and down 6.41 percentage points from the prior quarter.
Powered by 
Analysis
Acrivon Therapeutics (ACRV) Return on Assets [ROA] (2022 - 2026) Analysis & Trends
For FY2025, Acrivon Therapeutics' Return on Assets [ROA] came in at -51.56%, up 1.72 percentage points from FY2024.
- Annual Return on Assets [ROA] shows a three-year change of -29.90 percentage points (FY2022 to FY2025).
- In prior years, Acrivon Therapeutics' Return on Assets [ROA] was -53.28% in FY2024 (-11.27 pp), -42.01% in FY2023 (-20.35 pp) and -21.66% in FY2022.
- The Q2 2026 figure stands as the lowest quarterly Return on Assets [ROA] in data going back to Q4 2022.
- On a year-over-year basis, Return on Assets [ROA] has declined in each of the last five quarters, with an average year-over-year change of -10.65 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q1 2025, with a gain of 4.41 percentage points; the weakest was Q1 2024, with a drop of 32.51 percentage points.
- According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -69.34% (Q1 2026), -61.17% (Q4 2025) and -58.54% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 2.14% |
| 10 | Acrivon Therapeutics | 86.12 Mn | 86.12 Mn | - | -75.75% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -75.75% |
| Mar 31, 2026 | -69.34% |
| Dec 31, 2025 | -61.17% |
| Sep 30, 2025 | -58.54% |
| Jun 30, 2025 | -56.37% |
| Mar 31, 2025 | -49.98% |
| Dec 31, 2024 | -43.38% |
| Sep 30, 2024 | -38.31% |
| Jun 30, 2024 | -43.46% |
| Mar 31, 2024 | -54.39% |
| Dec 31, 2023 | -46.38% |
| Sep 30, 2023 | -35.34% |
| Jun 30, 2023 | -29.09% |
| Mar 31, 2023 | -21.88% |
| Dec 31, 2022 | -23.25% |
API Access
Acrivon Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ACRV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "ACRV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ACRV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();